The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 237
RetractedGabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
RetractedThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Suppression of cortical spreading depression in migraine prophylaxis
Ayata, C., Jin, H., Kudo, C., Dalkara, T., & Moskowitz, M. A. (2006) · Annals of Neurology · doi:10.1002/ana.20778 · Cited by 570
Chiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
Diener, H.-C., Bussone, G., Oene, J. V., Lahaye, M., Schwalen, S., & Goadsby, P. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01326.x · Cited by 561
New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine
Rowan, A. J., Ramsay, R. E., Collins, J. F., Pryor, F., Boardman, K. D., Uthman, B. M., Spitz, M., Frederick, T., Towne, A., Carter, G. S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167384.68207.3e · Cited by 509
Cited by
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Self-citationEfficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures
Ben‐Menachem, E., Biton, V., Jatuzis, D., Abou‐Khalil, B., Doty, P., & Rudd, G. D. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01188.x · Cited by 485
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Altered Lipid Metabolism in Brain Injury and Disorders
Adibhatla, R. M., & Hatcher, J. F. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 401
Halász, P., Kälviäinen, R., Mazurkiewicz‐Beldzińska, M., Rosenow, F., Doty, P., Hebert, D., Sullivan, T., & on behalf of the SP755 Study Group (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01951.x · Cited by 392
Mechanisms of Action of Antiepileptic Drugs
Czapinski, P., Blaszczyk, B., & Czuczwar, S. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386962 · Cited by 382
Idiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Self-citationValproate: Past, Present, and Future
Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363
Self-citationRufinamide for generalized seizures associated with Lennox–Gastaut syndrome
Glauser, T., Kluger, G., Sachdeo, R., Krauss, G., Perdomo, C., & Arroyo, S. (2008) · Neurology · doi:10.1212/01.wnl.0000303813.95800.0d · Cited by 356
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Pregabalin: Its Pharmacology and Use in Pain Management
Gajraj, N. M. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000287643.13410.5e · Cited by 343
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Perucca, E., French, J., & Bialer, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70215-6 · Cited by 339
Self-citationLacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial
Chung, S., Sperling, M. R., Biton, V., Krauss, G., Hebert, D., Rudd, G. D., Doty, P., & on behalf of the SP754 Study Group (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02496.x · Cited by 328
Drug interactions involving the new second- and third-generation antiepileptic drugs
Johannessen Landmark, C., & Patsalos, P. N. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.136 · Cited by 321
Johannessen Landmark, C. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00003 · Cited by 316
Revisiting AMPA Receptors as an Antiepileptic Drug Target
Rogawski, M. A. (2011) · Epilepsy Currents · doi:10.5698/1535-7511-11.2.56 · Cited by 316
Treatment of pediatric epilepsy: European expert opinion, 2007
Wheless, J. W., Clarke, D. F., Arzimanoglou, A., & Carpenter, D. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0144 · Cited by 295
Malykh, A. G., & Sadaie, M. R. (2010) · Drugs · doi:10.2165/11319230-000000000-00000 · Cited by 270
Role Of Lipids In Brain Injury And Diseases
Adibhatla, R. M., & Hatcher, J. F. (2007) · Future Lipidology · doi:10.2217/17460875.2.4.403 · Cited by 270
van Seventer, R., Feister, H. A., Young, J. P., Stoker, M., Versavel, M., & Rigaudy, L. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x80404 · Cited by 264
Biton, V., Berkovic, S. F., Abou‐Khalil, B., Sperling, M. R., Johnson, M. E., & Lu, S. (2014) · Epilepsia · doi:10.1111/epi.12433 · Cited by 253
Fragile X and autism: intertwined at the molecular level leading to targeted treatments
Hagerman, R., Hoem, G., & Hagerman, P. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-12 · Cited by 247
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.10.001 · Cited by 243
Self-citationPharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
Zonisamide or Levetiracetam for Adults With Cyclic Vomiting Syndrome: A Case Series
Clouse, R. E., Sayuk, G. S., Lustman, P. J., & Prakash, C. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.004 · Cited by 74
Effect of Various Antiepileptic Drugs in Zebrafish PTZ-Seizure Model.
(2014) · Europe PMC (PubMed Central) · Cited by 46
Metadata
- Authors
- Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T.
- Venue
- Epilepsy Research
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 73
- Issue
- 1
- Pages
- 1-52
- ISSN
- 0920-1211 (ISSN-L)
- OpenAlex
- W2025797846
- Cited by
- 477
- References
- 194
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.